Watchlist Price Alert

ADC Therapeutics SA (ADCT)

NYSE: ADCT · Real-Time Price · USD

1.70

-0.11 (-6.08%)

At close: May 15, 2025, 2:05 PM

ADC Therapeutics SA Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-157.85M	-240.05M	-155.8M	-230.03M	-246.29M	-116.48M	-123.1M	-89.86M
Depreciation & Amortization	3.28M	3.27M	2.33M	2.63M	2.19M	1.65M	740K	341K
Stock-Based Compensation	6.57M	13.49M	49.32M	60.48M	37.59M	1.12M	469K	980K
Other Working Capital	n/a	-8.3M	18.4M	6.16M	10.44M	-2.34M	-1.14M	-1.8M
Other Non-Cash Items	24.17M	23.23M	1.07M	-24.7M	25.1M	-1.19M	-891K	36K
Deferred Income Tax	n/a	37.1M	-708K	-21.48M	327K	1.21M	935K	48K
Change in Working Capital	n/a	44.27M	-33.01M	-20.28M	12.36M	-7.88M	481K	13.51M
Operating Cash Flow	-123.83M	-118.69M	-136.79M	-233.38M	-168.73M	-121.58M	-121.36M	-74.94M
Capital Expenditures	-867K	-3.22M	-2.3M	-6.38M	-2.81M	-2.15M	-2.47M	-3.16M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-210K	-297K	-19K	-100K	-36K	-92K
Investing Cash Flow	-867K	-3.22M	-2.51M	-6.67M	-2.83M	-2.25M	-2.51M	-3.25M
Debt Repayment	n/a	n/a	-2.71M	48.61M	61.75M	-1M	n/a	n/a
Common Stock Repurchased	n/a	n/a	-221K	n/a	n/a	-141K	-24K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	36.55M	73.88M	-4.32M	218.78M	54K	101.66M	-24K	n/a
Financial Cash Flow	97.05M	73.88M	-593K	267.39M	494.97M	100.51M	-24K	197.24M
Net Cash Flow	-27.73M	-47.84M	-140.1M	27.35M	323.64M	-23.26M	-123.94M	119.08M
Free Cash Flow	-124.7M	-121.9M	-139.09M	-239.75M	-171.54M	-123.73M	-123.83M	-78.1M